Kura Oncology, Inc. Profile Avatar - Palmy Investing

Kura Oncology, Inc.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are…

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Kura Oncology, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Kura Oncology, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Kura Oncology, Inc..

End of KURA's Analysis
CIK: 1422143 CUSIP: 50127T109 ISIN: US50127T1097 LEI: - UEI: -
Secondary Listings
KURA has no secondary listings inside our databases.